Looking for more information on Oligonucleotides?

Check out our exclusive recording of the presentation, "Biogen Platform Manufacturing Process for Antisense Oligonucleotides" from our CMC Workshop in April.

View the presentation slides and listen in as Xianglin Shi, PhD, explores the structures of therapeutic oligonucleotides and their actionable mechanisms, as well as the manufacturing process of antisense phosopharothioate oligonucleotides. Dr. Shi also reflects on what was learned from the Spinraza NDA filing.
Download Kit